About 87 percent did not seek care for menopausal symptoms, with most citing being too busy or lacking awareness about treatments
TUESDAY, Nov. 4, 2025 (HealthDay News) — Thirty-four percent of women report moderate, severe, or very severe menopause symptoms, but most women do not seek care for symptoms, according to a study published in the November issue of Mayo Clinic Proceedings.
Ekta Kapoor, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a cross-sectional study enrolling women aged 45 to 60 years from the Mayo Clinic Registry of Midlife Women (Hormones and Experiences of Aging) to examine the burden of menopause symptoms and potential barriers to receiving care. The participants completed questionnaires assessing their menopause experience; 4,914 responses were received.
The researchers found that 34 percent of the respondents reported moderate, severe, or very severe menopause symptoms; sleep and sexual problems were often rated as severe or very severe. Most women (about 87 percent) did not seek medical care for symptoms, with the main reasons reported as “being too busy” or “lacking awareness about effective treatment options.”
“Menopause is universal for women at midlife, the symptoms are common and disruptive, and yet, few women are receiving care that could help them,” Kapoor said in a statement. “This gap has real consequences for women”s health and quality of life, and it”s time we address it more proactively.”
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
Type 2 Diabetes Linked to Worse Menopausal Symptoms
Body Fat Percentage May Be Better Indicator of Men"s Reproductive Health Than BMI
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer
Sex Hormones Linked to Cardiovascular Events in Men With Type 2 Diabetes
Appropriate Duration of ADT in Prostate Cancer Depends on Risk